1-3 of 3
Ruth Schwab
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Arginine (R) at Position 595 in FLT3 Is Critical for Transforming Potential of FLT3-Length Mutations.

Sridhar Vempati, MSc, Ruth Schwab, Theodora Malamoussi, Martin Dugas, MD, Gudrun Mellert, Susanne Schnittger, PhD, Wolfgang Hiddemann, MD, PhD, Karsten Spiekermann, MD
Journal: Blood
Blood (2005) 106 (11): 1598.
https://doi.org/10.1182/blood.V106.11.1598.1598
Published: 2005
Journal Articles

Mutations in the tyrosine kinase domain of FLT3 define a new molecular mechanism of acquired drug resistance to PTK inhibitors in FLT3-ITD–transformed hematopoietic cells

Ksenia Bagrintseva, Ruth Schwab, Tobias M. Kohl, Susanne Schnittger, Sabine Eichenlaub, Joachim W. Ellwart, Wolfgang Hiddemann, Karsten Spiekermann
Journal: Blood
Blood (2004) 103 (6): 2266–2275.
https://doi.org/10.1182/blood-2003-05-1653
Published: 2004
Journal Articles

The protein tyrosine kinase inhibitor SU5614 inhibits FLT3 and induces growth arrest and apoptosis in AML-derived cell lines expressing a constitutively activated FLT3

Karsten Spiekermann, Ralf J. Dirschinger, Ruth Schwab, Ksenia Bagrintseva, Florian Faber, Christian Buske, Susanne Schnittger, Louise M. Kelly, D. Gary Gilliland, Wolfgang Hiddemann
Journal: Blood
Blood (2003) 101 (4): 1494–1504.
https://doi.org/10.1182/blood-2002-04-1045
Published: 2003